1) National TAZ/PIPC
国产他唑巴坦/哌拉西林
2) piperacillin-tazobactam
哌拉西林-他唑巴坦
1.
Cost-effectiveness analysis on piperacillin-sulbactam and piperacillin-tazobactam in the treatment of bacterial infection in lower respiratory tracts;
国产哌拉西林-舒巴坦与进口哌拉西林-他唑巴坦治疗下呼吸道感染的成本-效果分析
2.
Cost-effectiveness analysis of piperacillin-tazobactam vs ceftriaxone in treatment of lower respiratory tract infection;
哌拉西林-他唑巴坦与头孢曲松治疗下呼吸道感染的成本-效果比较
3.
Of the 35 patients receiving piperacillin-tazobactam,7 developed bacterial resistance.
9%氯化钠注射液100 ml静脉滴注,1次/8 h;35例用哌拉西林-他唑巴坦4。
3) Piperacillin/tazobactam
哌拉西林/他唑巴坦
1.
Bloody stools related to intravenous infusion of piperacillin/tazobactam;
哌拉西林/他唑巴坦静脉滴注引起血便
2.
Piperacillin/tazobactam for Acute Exacerbation of Chronic Obstructive Pulmonary Disease with Pulmonary Encephalopathy:A Clinical Analysis;
哌拉西林/他唑巴坦治疗急性加重期慢性阻塞性肺病并肺性脑病临床分析
3.
Piperacillin/tazobactam in treatment of severe craniocerebral injury complicated pulmonary infection:a clinical study;
哌拉西林/他唑巴坦治疗重型颅脑损伤合并肺部感染的临床研究
4) piperacillin/tazobactam
哌拉西林他唑巴坦
1.
A randomized single-blind controlled trial of piperacillin/sulbactam and piperacillin/tazobactam in treatment of bacterial infections;
哌拉西林舒巴坦与哌拉西林他唑巴坦随机单盲对照治疗细菌感染
6) piperacillin sodium and tazobactam sodium for injection
注射用哌拉西林钠他唑巴坦钠
1.
Methods The stability of piperacillin sodium and tazobactam sodium for injection was studied by influencing factor test,accelerated test,long-term test and solution compatibility stability test.
目的考察注射用哌拉西林钠他唑巴坦钠(4∶1)制剂的稳定性和配伍稳定性。
补充资料：哌拉西林酸
分子式：暂无
分子量：暂无
CAS号：暂无
性质：暂无
制备方法：暂无
用途：暂无
分子量：暂无
CAS号：暂无
性质：暂无
制备方法：暂无
用途：暂无
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条